Press-release for stocks related to injection for NOVN

Prices are updated after-hours

Novan’s NITRICIL™ Technology Shows In Vitro Antiviral Effect Against SARS-CoV-2 in Human Airway Infection Model
Published: 2020-10-14 (Crawled : 22:13) - globenewswire.com
NOVN | $0.0941 -24.84% -32.91% 7.2M

| -79.54% | O: 61.52% H: 0.94% C: -23.15%
antiviral injection xin sars-cov-2 infections in vitro

67%

33%

AGBA | News | $1.26 215.0% 68.25% 130M

EGOX | $0.0515 43.06% 30.1% 330M

OLB 4 | $0.33 -14.95% 25.53% 840K

NVFY | $2.77 31.28% 23.83% 33M

ZCMD | $1.87 28.97% 22.46% 31M

RCON | $0.1112 13.01% 21.28% 1.7M

INSG | $3.03 25.21% 20.13% 330K

GCTK | $0.8191 22.25% 18.2% 190K

WLGS | $0.59 18.0% 17.9% 2.3M

ASNS | $0.828 21.75% 17.86% 18K

Save your searches and get alerts when important news are released.